Results 131 to 140 of about 82,470 (284)
A case of disseminated aspergillosis in dog was described due to an atypical strain of Aspergillus floccosus. Aspergillosis should be considered in the differential diagnosis of dogs with neurological signs and nonspecific changes in CBC or CMP, particularly in German Shepherd dogs.
Talita Bordoni+6 more
wiley +1 more source
Newsletter of the Evans Memorial Department of Clinical Research and Preventive Medicine at University ...
Levinsky, Norman G.+1 more
core
Phage antibiotic combinations have proven particularly successful against Pseudomonas in the clinic (right) and in the lab (left), but the connections between the two are tenuous. Here, we explore the mechanisms and measurements of the latter and highlight which are likely ill‐suited to treatment success.
Rabia Fatima, Alexander P. Hynes
wiley +1 more source
Fluconazole prophylaxis in preterm infants: a systematic review
Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios+3 more
doaj
DRUG POINTS: Fixed drug eruption with fluconazole [PDF]
J M Morgan, A.J. Carmichael
openalex +1 more source
ABSTRACT Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH)2 and EZH1, approved in Japan for the treatment of relapsed or refractory peripheral T‐cell lymphoma, including adult T‐cell leukemia/lymphoma, and globally under investigation for the treatment of non‐Hodgkin lymphomas and solid tumors.
Masaya Tachibana+5 more
wiley +1 more source
Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro [PDF]
Michael R. Yeaman+5 more
openalex +1 more source
Involvement of People Living with HIV/AIDS in Treatment Preparedness in Thailand [PDF]
Perspective and Practice in Antiretroviral Treatment: Case ...
Kumphitak, A+4 more
core +1 more source
A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley +1 more source
Fluconazole in neonatal disseminated candidiasis. [PDF]
Dawn Wiest+3 more
openalex +1 more source